Full title: Scopolamine in Bipolar Depression

Details: The primary objective of the SCOPE-BD study is to investigate the efficacy and safety of IV Scopolamine, compared to placebo, in reducing severity of depression in individuals with bipolar disorder who are experiencing a depressive episode of at least moderate severity


Specialty: Psychiatry

Principal Investigator: Dr Brian Hallahan

Study status: Recruiting

Identifier: NCT04211961